[Pj-39] Japanese Poster Session 39 Neuroimmunology 06

[Pj-39-8] Safety and effectiveness of natalizumab in a real-world clinical setting in Japanese MS patients

^○Kazumasa Yokoyama¹, Ryusuke Sato², Haruki Makioka², Michihiro Kanda², Mingshou Jin², Takahiko Saida³ (1.Department of Neurology, Juntendo University Hospital, Japan, 2.Biogen Japan Ltd., 3.Kansai Multiple Sclerosis Center, Kyoto Min-iren Chuo Hospital)